The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden

Gelijkaardige items

• Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers
  door: Gessoni, Gianluca, et al.
  Gepubliceerd in: (2017)
• Factor V Leiden in Chioggia: a prevalence study in patients with venous thrombosis, their blood relatives and the general population
  door: Gessoni, Gianluca, et al.
  Gepubliceerd in: (2010)
• Sclerosing Mesenteritis in a Patient Heterozygous for Factor V Leiden
  door: Reddington, Hayley, et al.
  Gepubliceerd in: (2020)
• Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state
  door: Wood, Jeremy P., et al.
  Gepubliceerd in: (2017)
• Antiphospholipid antibodies and pregnancy outcomes in women heterozygous for Factor V Leiden
  door: Manuck, Tracy, et al.
  Gepubliceerd in: (2010)